Bio-Vascular purchases Peri-Guard patent:
This article was originally published in Clinica
Executive Summary
Bio-Vascular (US) has purchased the patent for Peri-Guard from Uroplasty for an undisclosed sum. The acquisition gives Bio- Vascular outright ownership and unrestricted use of Peri-Guard. Bio-Vascular also granted Uroplasty a non-exclusive, royalty-free licence for restricted use of the Peri-Guard and the Supple Peri-Guard processes in urological applications.